Globus Medical, Inc. (GMED)

Market Cap	5.57B
Revenue (ttm)	1.02B
Net Income (ttm)	190.17M
Shares Out	100.31M
EPS (ttm)	1.85
PE Ratio	28.90
Forward PE	32.26
Dividend	n/a
Ex-Dividend Date	n/a

Volume	214,917
Open	54.80
Previous Close	53.47
Day's Range	54.55 - 55.27
52-Week Range	50.92 - 81.78
Beta	1.05
Analysts	Buy
Price Target	68.51 (+23.96%)
Earnings Date	May 8, 2023

About GMED

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspi...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Aug 3, 2012
• Employees: 2,400
• Stock Exchange: NYSE
• Ticker Symbol: GMED

Financial Performance

In 2022, Globus Medical's revenue was $1.02 billion, an increase of 6.76% compared to the previous year's $958.10 million. Earnings were $190.17 million, an increase of 27.47%.

Analyst Forecast

According to 22 analysts, the average rating for GMED stock is "Buy." The 12-month stock price forecast is $68.51, which is an increase of 23.96% from the latest price.

Price Target

$68.51

(23.96% upside)

Analyst Consensus: Buy